Search keyWord :

Trip.com Group Limited Reports Unaudited Fourth Quarter and Full Year of 2024 Financial Results

Feb 26, 2025

SINGAPORE,Feb. 25,2025--Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"),a leading one-stop travel service provider of accommodation reservatio

ATFX Illuminates the Future with 2025 Annual Gala Dinner

Feb 26, 2025

KUALA LUMPUR,Malaysia,Feb. 25,2025-- On February 22,2025,ATFX hosted its highly anticipated Gala Dinner at the prestigious Shangri-La Hotel in Kuala Lumpur,bringing together over 600 employees from 23

GENERAL LINK Inc. Launches Special Campaign for Overseas Guests at GL Terrace

Feb 26, 2025

TOKYO,Feb. 25,2025-- GENERAL LINK Inc. has announced an exciting new campaign starting March 1st,2025,aimed at overseas travelers visiting Japan. The campaign will offer free optionsatGL Terrace, a lu

Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets

Feb 26, 2025

HONG KONG,Feb. 25,2025-- On 21 February,Guo Guangchang,Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025,stating that private enterprises are

"The Future of Travel": Trip.com Group to Showcase Next-Gen Tech at ITB Berlin 2025

Feb 26, 2025

Trip.com Group to launch joint Technology Game Changers: Future Trends in Travel & Tourism report at ITB Berlin Press Conference

ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

Feb 26, 2025

6.3% Increase in Full Year 2024 Revenue Compared to Prior Year 13.0% Full Year 2024 Gross Margin Compared to 16.6% in 2023

Ericsson announces changes to the Executive Team and to the Market Area structure

Feb 26, 2025

Per Narvinger,currently Head of Business Area Cloud Software and Services,is appointed Executive Vice President and new Head of Business Area Networks as of March 15,2025

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

Feb 26, 2025

SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr

ZTO to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 18, 2025 U.S. Eastern Time

Feb 26, 2025

SHANGHAI,Feb. 25,2025-- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"),a leading and fast-growing express delivery company inChina,today announced th

CNPC's Well Shendi Take-1 reaches 10,910-meter milestone

Feb 26, 2025

BEIJING,Feb. 25,2025-- A news report from chinadaily.com.cn: On February 20,China National Petroleum Corporation (CNPC) announced the successful completion of the Well Shendi Take-1,reaching an impres

1 ... 215 216 217 218 219 220 221 ... 1253